Purchase Order HHSN276201500020P

<p>The U.S. National Institute of Diabetes and Digestive and Kidney Diseases awarded a $9,426.00 firm-fixed-price purchase order to Seahorse Bioscience, Inc. for time and materials repair and maintenance of the XF Analyzer. This award was not set aside. Seahorse Bioscience, Inc. is a for-profit manufacturer of goods. The award was made on July 17, 2015, with a completion date of July 20, 2015.</p>

<p>This federal contract award, identified as HHSN275201300406P, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Seahorse Bioscience, Inc. (Seahorse Labware), a for-profit manufacturer. The $15,649.20 firm-fixed-price purchase order is for a &quot;Service Agreement for XF96 Analyzer&quot;, with a completion date of September 24, 2014. The contract does not have a set-aside designation.</p>

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Seahorse Bioscience, Inc. on August 7, 2013. The contract has a ceiling value of $7,343.10 and a period of performance through August 6, 2014. The contract does not have a set-aside designation. Seahorse Bioscience, Inc., doing business as Seahorse Labware, is the prime contractor. The contract is for the delivery of unspecified products or...

This is a federal contract award from the National Institute of Child Health and Human Development, a civilian agency, to Seahorse Bioscience, Inc. for the purchase of Seahorse Labware products. The firm-fixed-price purchase order has a ceiling value of $7,717.50 and an ultimate completion date of August 6, 2015. The contract was awarded on August 7, 2014 and was not set aside for any socioeconomic category. Seahorse Bioscience, Inc. is the prime contractor and no subcontractors are mentioned.

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $3,210 purchase order to Seahorse Bioscience, Inc., doing business as Seahorse Labware. The firm fixed price contract is for Seahorse XF96 Extracellular Flux Analyzer two-day on-site training to be conducted in Bethesda, Maryland between November 28 and December 31, 2012. No subcontractors or set aside designations were identified. The training...

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $2,942 purchase order to Seahorse Bioscience, Inc., doing business as Seahorse Labware, a subsidiary of Agilent Technologies, Inc. The firm fixed price contract is for maintenance services on the Seahorse XF96 instrument and will be performed at Seahorse's facility in North Billerica, Massachusetts over a one year period concluding in April 2017. No...

<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to Seahorse Bioscience, Inc. for the procurement of a Seahorse Bioscience, Inc. XFE96 Extracellular Flux Metabolic Analyzer System. The total ceiling value of the contract is $175,024.00. The contract has an ultimate completion date of June 29, 2016 and was awarded on June 30, 2015. The contract is not associated with a set-aside designation.</p>

This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Seahorse Bioscience, Inc. for an &quot;Extracellular Flux Analyzer&quot; at a firm fixed price of $216,755.20. The contract was awarded on July 13, 2015 with a completion date of September 30, 2015. There was no set-aside designation for this award. Seahorse Bioscience, Inc. is the prime contractor, and the contract does not mention any major subcontractors. The FDA is the funding agency for...

This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Agilent Technologies Inc. Customer Service And Sales Division for a Seahorse XFE96 Analyzer 64-bit instrument. The award ceiling value is $268,318.98 and the contract completion date is November 30, 2020. No set-aside designation was used for this award. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied...

This federal contract award, valued at $4,830.40, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the U.S. Department of Health and Human Services (HHS). The contract was awarded to Thermo Fisher Scientific (Asheville) LLC, a subsidiary of Thermo Electron Corporation, without any set-aside designation. The contract is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. It supports the procurement of a...